U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07531628) titled 'A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants' on April 09.
Brief Summary: To assess pharmacokinetics, safety, and tolerability of multiple oral doses of verducatib in healthy Chinese male and female trial participants in order to facilitate the clinical development of verducatib in China.
Study Start Date: July 13, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Verducatib
Verducatib
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Published by HT Digital Content Services with permission from Health Daily Digest....